ARCHIVES

Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

CCOPs Payline Set At 211, Winners Lister; NCI Will Fund Only 51 Unless More Funds Added

March 16, 1990

NCCS Networker Volume 9 Issue 1, Spring 1995

April 13, 1995

Blues Association, 2 cooperative Groups Form Pediatric Network

April 19, 1996

NCI Signs Letters Of Intent With Latin American Countries

October 2, 2009

Missouri Center Director Search Narrowed To Vincent, Wiernik

September 10, 1982

NCAB Members Skeptical On NCI Reorganization; King Has “Alterative;” Terry T Head Centers

January 27, 1978